Overview

Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence

Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate ideal dose or lisdexamfetamine and tolerability, plus reduction in cocaine use and craving.
Phase:
Phase 1
Details
Lead Sponsor:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Treatments:
Cocaine
Lisdexamfetamine Dimesylate